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The Tet 5-methylcytosine dioxygenases catalyze DNA demethylation by producing 5-hydroxymethylcytosine and further oxi-
dized products. Tet1 and Tet2 are highly expressed in mouse pluripotent cells and downregulated to different extents in somatic
cells, but the transcriptional mechanisms are unclear. Here we defined the promoter and enhancer domains in Tet1 and Tet2.
Within a 15-kb “superenhancer” of Tet1, there are two transcription start sites (TSSs) with different activation patterns during
development. A 6-kb promoter region upstream of the distal TSS is highly active in naive pluripotent cells, autonomously re-
ports Tet1 expression in a transgenic system, and rapidly undergoes DNAmethylation and silencing upon differentiation in cul-
tured cells and native epiblast. A second TSS downstream, associated with a constitutively weak CpG-rich promoter, is activated
by a neighboring enhancer in naive embryonic stem cells (ESCs) and primed epiblast-like cells (EpiLCs). Tet2 has a CpG island
promoter with pluripotency-independent activity and an ESC-specific distal intragenic enhancer; the latter is rapidly downregu-
lated in EpiLCs. Our study reveals distinct modes of transcriptional regulation at Tet1 and Tet2 during cell state transitions of
early development. New transgenic reporters using Tet1 and Tet2 cis-regulatory domains may serve to distinguish nuanced
changes in pluripotent states and the underlying epigenetic variations.
The study of transcription regulation is fundamental to under-stand how gene expression and phenotype are regulated dur-
ing development. ENCODE (encyclopedia of DNA elements)
studies recently revealed that the mammalian genome is more
complex than previously annotated, in which different transcrip-
tion start sites (TSSs) often mark core promoters, both intra- and
intergenic, to drive the expression of alternative mRNA isoforms
(1, 2). Distal elements known as enhancers are often recruitment
platforms for cell-type-specific transcription factors and interact
with promoter-bound factors to stabilize the association of RNA
polymerase II (Pol II) at TSSs (3).
Embryonic stem cells (ESCs) derived from the inner cell mass
(ICM) of mouse blastocysts represent a unique model of tran-
scription regulation. The widespread presence of “open” chroma-
tin achieved through feed-forward and autoregulatory loops in-
volving transcription factors appears crucial for the transcriptome
to adapt rapidly to inductive differentiation signals, allowing the
cells to generate all early embryonic lineages (4, 5). This pluripo-
tent state is dependent on the master transcription factors Oct4,
Sox2, and Nanog (OSN), which often bind cooperatively at target
sites on enhancers. In early mammalian development, the triad of
OSN, by binding to different enhancers, orchestrates two states of
pluripotency, the “naive” and “primed” conditions resembling
the pre- and postimplantation epiblasts, respectively (6, 7). Fur-
thermore, OSN together with Klf4, Esrrb, andMediator coactiva-
tor, all highly expressed in naive ESCs, densely occupy extended
domains of enhancer clusters, named “superenhancers,” which
are associated with genes that playmajor roles in ESC identity (8).
During differentiation, superenhancer-associated genes are highly
sensitive to reducedMediator occupancy and are rapidly silenced.
Among the list of superenhancer-associated genes in ESCs are
Tet1 and Tet2, encoding DNA-modifying enzymes (8). Together
with Tet3, the TET dioxygenases act on 5-methylcytosine (5mC),
the preeminent mark of DNAmethylation in the mammalian ge-
nome, to generate 5-hydroxymethylcytosine (5hmC), 5-formyl-
cytosine (5fC), and 5-carboxycytosine (5caC) (9–11). The reiter-
ative oxidation steps constitute both passive and active pathways
in DNA demethylation; at the genome scale, this process is a fun-
damental part of epigenetic reprogramming (12). Tet1 and Tet2
are highly expressed in mouse ESCs and primordial germ cells
relative to somatic cells: both have been implicated in early em-
bryonic differentiation (13, 14), primordial germ cell specification
(15, 16), imprinting (17, 18), and induced pluripotency (19, 20).
In the adult, TET2 shows broader tissue-specific expression than
doesTET1 (21).Tet3, although not part of the ESC gene signature,
is expressed highly in many tissues, including oocytes, where it
contributes to DNA hydroxymethylation in the paternal genome
early postfertilization (22). The loss of 5hmC and TET expression
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is also a hallmark of many cancers (23, 24). Despite many studies
on TET using loss- and gain-of-function approaches, the tran-
scriptional mechanism underlying their tissue-specific expression
remains to be clarified.
We previously showed that Tet1 and Tet2 expressions are de-
pendent on Oct4 and Sox2 (13). Using mouse-human sequence
conservation to predict regulatory elements, we identified con-
served Oct4 sites in Tet1 and Tet2. A subsequent study suggests
that Oct4, but not Sox2, is required for Tet2 transcription by act-
ing at the conserved Oct4-Sox2 motif (25). In this study, we iden-
tified the TSS of Tet1 by 5= rapid amplification of cDNA ends (5=
RACE). Using previously reported high-coverage chromatin im-
munoprecipitation coupled with massively parallel sequencing
(ChIP-seq) data sets, we defined promoter and enhancer regions
in Tet1 and Tet2, including additional elements in the superen-
hancer domains, and validated their cell state-specific activities by
cell-based reporter assays. In addition, we examined the contribu-
tion of Oct4 and Sox2 motifs within the enhancer domains to
transcription factor occupancy and gene expression. Finally, we
examinedDNAmethylation changes at specific regulatory regions
during early pluripotency states and differentiation.
MATERIALS AND METHODS
Cell culture. Themouse v6.5 ESC line (C57BL/6 129/sv F1 hybrid) was
cultured in standard ESCmedium on feeder layer as previously described
(13). Cells were harvested by trypsin-EDTA treatment and replated twice
on tissue culture wells over 30 to 45 min to remove the adherent feeders
from the ESC in suspension. Culture in defined medium containing dual
MEK and glycogen synthase kinase (GSK) inhibitors (2i medium and
differentiation toward epiblast-like cells (EpiLCs) were performed as pre-
viously described (6). The epiblast-derived stem cell (EpiSC) lines FT.1,
FT.2, and FT.3 (26) were a generous gift from Alice Jouneau. NIH 3T3 (a
kind gift from Francois Fuks) and HEK293T cells were cultured under
standard conditions in high-glucoseDulbecco’smodified Eagle’smedium
(DMEM) supplemented with GlutaMAX and 10% fetal bovine serum
(FBS) (Sigma-Aldrich).
Mouse embryos and adult tissues.Embryoswere isolated bymechan-
ical dissection of the decidua isolated from the uterine lining of naturally
mated C57BL/6 mice. Epiblasts from mice at embryonic day 6.0 postco-
itum (E6.0) to E7.0 were extracted by first dissecting the embryos free of
Reichert’s membrane and peripheral trophectodermal tissues with the aid
of fine tungsten needles. Next, the embryonic visceral endoderm was re-
moved by incubating the embryos for 10 min at 4°C in 2.5% pancreatin–
0.5% trypsin solution (in Ca2/Mg2-free Tyrode Ringer’s saline). Fi-
nally, the epiblasts were separated from all other extraembryonic tissues.
Each epiblast samplewas pooled from3 to 5 embryos for RNAor genomic
DNA extraction. Embryos from E8.5 to E10.5 were dissected free of yolk
sac and amnion.Mouse embryonic fibroblasts (MEFs) were derived from
E13.5 mouse embryos and cultured for 2 to 3 passages before harvest.
Adult tissues were dissected from 6- to 8-week-old female mice. All ex-
perimental procedures on mice have been reviewed and approved by the
KU Leuven Ethical Committee for Animal Experimentation (P177/2011)
in compliance with the European Directive 2010/63/EU.
5= rapid amplification of cDNA ends. Total RNA was isolated by us-
ing TRIzol for 5= RACE as according to the manufacturer’s instructions
(Invitrogen). Briefly, cDNA was synthesized with SuperScript II reverse
transcriptase by using a gene-specific primer (see Table S1 in the supple-
mental material). A 3= homopolymeric cytosine or adenine tail was added
by using terminal deoxynucleotidyltransferase (TdT) for PCR amplifica-
tion. Purified PCR products were cloned into TOPO 2.1 (Invitrogen) for
sequencing.
Quantitative reverse transcription-PCR (RT-PCR). Total RNA was
extracted from tissues following homogenization in TRIzol (Invitrogen)
according to themanufacturer’s instructions. RNAwas purified fromcells
or from pooled epiblasts/individual embryos by using the RNeasyminikit
or microkit, respectively (Qiagen), with on-column DNase I digestion.
cDNAwas synthesized by using SuperScript III (Invitrogen).Quantitative
PCR (qPCR) was performed by using SYBR green PCR master mix (In-
vitrogen) on a StepOnePlus or ViiA7 real-time PCR system (Life Tech-
nologies). Absolute standard curves were generated by 10-fold serial dilu-
tions of plasmid clones containing target sequences, starting from 105 or
106 copies estimated based onmass concentration. Transcript copy num-
berswere determined by calibration to standard curves andnormalized by
Gapdh gene copy numbers.
ChIP-seq analysis. ChIP-seq Sequence Read Archive (SRA) files
were obtained from the GEO (see Table S2 in the supplemental mate-
rial). Reads were aligned to mm9 by using the command line (-e 70 -k
1 -m 1 -n 2 -best -concise) on the software BowTie. Peaks were then
identified by using MACS (model-based analysis of ChIP-seq) (66),
using a two-sided comparison with input DNA when available, with
default parameters (27).
Reporter plasmid construction.Genomic fragments ofTet1 andTet2
were amplified from the bacterial artificial chromosome (BAC) genomic
clones RP23-132J10 and RP24-333H9, respectively, by using KOD DNA
polymerase (Novagen). Primers for subcloning are listed in Table S1 in
the supplemental material. Putative promoter fragments were subcloned
into the pGL3-Basic vector (Promega) at either the MluI/XhoI or KpnI/
XhoI sites. Putative enhancer fragments were subcloned into the pGL-3-
Promoter vector (Promega), containing aminimal simian virus 40 (SV40)
promoter (or endogenous Tet1 and Tet2 promoter fragments), at the
downstream SalI site in either the sense or antisense orientation to the
luciferase gene (Luc). Methylated plasmids were generated in vitro by
treating 10 to 18 g of plasmids with 80 U CpGmethyltransferase M.SssI
(New England BioLabs) in NEBuffer2 containing 640M S-adenosylme-
thionine for 4 h at 37°C. Completemethylation was verified by protection
against cleavage by HpaII and by bisulfite sequencing of promoter re-
gions.
Site-directed mutagenesis. High-performance liquid chromatogra-
phy (HPLC)-purified primers containing sequence modifications were
used for PCR with KOD DNA polymerase (Novagen). The product was
subjected to DpnI (Promega) treatment to digest the parental vector. The
linear vector was gel purified, phosphorylated by using T4 polynucleotide
kinase (Thermo Scientific), ligated by using T4 DNA polymerase (New
England BioLabs), and transformed into competent bacteria. Modified
fragments were verified by sequencing and further subcloned into the
pGL3-Promoter vector(s).
Dual-Luciferase reporter assay.On the day of transfection, v6.5 ESCs
were seeded at 1 105 to 2 105 cells per well of a 12-well plate contain-
ing feeder cells for transfection using Lipofectamine 2000 (Invitrogen). To
transfect cells during the ESC-to-EpiLC conversion, 2i ESCs were seeded
at 0.7 105 to 1 105 cells per well of a 12-well plate on day 0 in EpiLC
differentiation medium and transfected as adherent cells on day 1; as
controls, ESCswere seeded at similar densities in standard serummedium
with leukemia inhibitory factor (LIF) on gelatin-coated plates and trans-
fected in parallel. NIH 3T3 cells were seeded at 1 105 to 2 105 cells per
well of a 6-well plate and transfected the next day as adherent cells by using
TransIT-3T3 (Mirus Bio). All pGL3 constructs were cotransfected with
pRL-TK at a ratio of 10:1 to normalize the transfection efficiency. Cells
were harvested 2 days after transfection (or 36 h after the ESC-to-EpiLC
conversion) for measurement of luciferase activities by using a Dual-Lu-
ciferase reporter assay system (Promega). Data are means  standard
errors of themeans (SEM) from at least 3 independent transfections, each
performed in duplicate.
Electrophoretic mobility shift assay. Nuclear extracts (NEs) from
ESCs or HEK293T cells were prepared from 2  107 to 5  107 cells, as
previously described (28). Oligonucleotides with 5= overhangs containing
guanine(s) were hybridized, filled in with [-32P]dCTP using Klenow
fragments, and purified on a Sephadex column as labeled probes. A total
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of 5 to 10 g of the NE was incubated with the probe (20,000 cpm) on ice
for 20min in 1 binding buffer (20mMHEPES [pH 7.9], 0.1mMEDTA,
5mMMgCl2, 17% [vol/vol] glycerol, 100mMNaCl) containing 50 ng/l
poly(dI·dC) (Sigma-Aldrich), 20 mM dithiothreitol (DTT), and 1% Tri-
ton X. Supershift was performed by adding the antibodies for Sox2 (sc-
17320) (28) and Oct4 (sc-5279) (Santa Cruz Biotech) to the NEs in bind-
ing buffer for 20 min, followed by the addition of labeled probe and
incubation on ice for an additional 20 min. Similarly, unlabeled (cold)
competitor duplex oligonucleotides were added at a 100 to 300molar
excess.
Bisulfite sequencing. Genomic DNAs were purified and bisulfite
treated by using an EpiTect bisulfite conversion kit (Qiagen). Pooled epi-
blast specimens were processed by using the EpiTect Plus LyseAll bisulfite
kit (Qiagen). Tet-assisted bisulfite (TAB) sequencing was performed by
using the 5hmC TAB-Seq kit according to the manufacturer’s protocol
(WiseGene). PCR products were generated by using Hifi Taq polymerase
(Invitrogen), gel purified, and subcloned into the pGEM-T Easy vector
(Promega) for sequencing. The CpG methylation status of the sequences
was analyzed using QUMA (67). Samples with a conversion rate of95%
and a sequence identity of90%, as well as identical bisulfite sequences,
were excluded. Primers for bisulfite PCR are listed in Table S1 in the
supplemental material.
Generationof a fluorescence reporter transgenic line.ThepGmch2p
construct was derived from the pGL3 vector by removal of the Luc gene
between the HindIII and XbaI sites and replacement with a bicistronic
cassette of mCherry and a puromycin resistance open reading frame
(ORF) linked by a viral 2A peptide (mCherry-2A-PuR). Thirty micro-
grams of purified, NotI-linearized plasmid was electroporated into 1 
107 v6.5 ESCs at 320 V and 250 F by using a Gene Pulser XCell system
(Bio-Rad). Electroporated cells were plated onto puromycin-resistant
feeders and treated 24 h later with 1.5g/ml puromycin for 7 to 10 days to
select for resistant colonies. mCherry-positive clones were picked and
propagated under standard ESC culture conditions. Cellular fluorescence
wasmonitored and imaged with a Zeiss Axiovert 40 CFLmicroscope. Cell
suspensions were collected for flow cytometry on a MACSQuant VYB
instrument and analyzed by using FlowJo software.
Statistical analysis. The significance of mean differences was calcu-
lated by analysis of variance (ANOVA) and a multiple-comparison post
hoc test using GraphPad Prism. P values of0.05 were considered statis-
tically significant.
Accession numbers. Clonal sequences obtained by 5= RACE analyses
of Tet1 as shown in Fig S1 in the supplemental material have been depos-
ited at the European Nucleotide Archive under accession numbers
LN810022 to LN810047 and are accessible on at www.ebi.ac.uk/ena/data
/view/LN810022-LN810047. The NCBI Reference Sequence (RefSeq)
number for the Tet1 mRNA transcript as shown in the UCSC genome
browser is NM_001253857.1. The genome build of NCBI Mus musculus
Annotation Release 104 contains additional mRNA reference sequences
predicted by automated computational analysis: the 5= untranslated re-
gion (UTR) starting with exon 1b as described in this study matches se-
quences under accession numbers XM_006513873.1, XM_006513866.1,
XM_006513868.1, and XR_380416.1; the 5= UTR starting with the exon
1a sequence as annotated in this study matches a sequence under acces-
sion number XM_006513867.1; a variant exon 1a sequence (found in 5=
RACE clones 7 and 10 as shown in Fig. S1E) matches the sequence under
accession number XM_006513869.1.
RESULTS
Identification of two cell state-dependent TSSs in Tet1. The
NCBI reference murine Tet1mRNA transcript lacks a 5= untrans-
lated region (UTR). To determine the TSS of Tet1, we performed
5= RACE with mouse v6.5 ESCs (see Fig. S1 in the supplemental
material). All sequenced clonal products had in common a 119-bp
5=UTR contiguous with the coding sequence (CDS), constituting
exon 2, but spliced to different noncoding exons (exon 1) up-
stream. Themajority (21 of 28 clones) of 5= ends alignedwith a site
12.7 kb upstreamof exon 2, here denoted exon 1b (Fig. 1A; see also
Fig. S1 in the supplemental material). A few clones (4 of 28)
mapped to a site 7.2 kb upstream, denoted exon 1a, which shares
sequence similarity with noncoding exon 1 annotated in human
TET1 (Fig. 1A). The remaining clones (3 of 28) mapped to differ-
ent sites further upstream of exon 1b but, as they were minor
products, were not investigated further (see Fig. S1E in the sup-
plemental material). Both exons 1a and 1b aligned with strong
binding peaks of the initiating form of Pol II (Pol2_5P) in the
mouse ESC genome (29), consistent with both sites having TSSs.
Binding peaks for the elongation form (Pol2_2P) suggest active
transcription across the gene body downstream of exon 1a. Weak
Pol II peaks were also detected in the vicinity of the Ensembl
noncoding exon (ENSMUSE00000930068) located 18.8 kb up-
stream of the CDS, which we denote exon 1c (Fig. 1A), although
this transcript was never detected by 5= RACE.
To measure the relative abundance of these 5=-UTR transcript
variants, we performed quantitative RT-PCR (qPCR) using a for-
ward primer specific for each noncoding exon (exons 1a, 1b, and
1c) paired with a common reverse primer in exon 2 (Fig. 1A; see
also Fig. S2A in the supplemental material). All three spliced 5=-
UTR variants were detected in mouse ESCs by RT-PCR (see Fig.
S2B in the supplementalmaterial). Levels of expression of 5=-UTR
variants were compared to that from a coding region (detected by
using a primer pair specific for exons 12 and 13) in terms of tran-
script copy numbers. Based on these measurements, the TSS at
exon 1b appeared to be the most active; transcript copy numbers
detected at exon 1b exceeded those detected at the 3= coding re-
gion and those at exon 1a by 2-fold and 6-fold, respectively (2.1-
0.3-fold and 6.0- 0.8-fold) (n 6) (Fig. 1B). Transcripts start-
ing from exon 1c were hardly detectable (see Fig. S2C in the sup-
plemental material). The greater abundance of 5=-end transcripts
than of full-length copies suggests a steady-state level of transcrip-
tional initiation exceeding elongation at the Tet1 TSS, which is
indicative of regulation at the postinitiation step. A genome-wide
analysis using human cells described transcription initiation at
most genes, only a subset of which experiences elongation, as a
general phenomenon (30).
We observed simiilar transcript profiles for Tet1 in feeder-cul-
tured mouse ESCs and induced pluripotent stem cells (iPSCs)
(Fig. 1B). To determine whether this profile reflects heterogeneity
within ESC cultures, we compared feeder-free cultures of ESCs
maintained with exogenous leukemia inhibitory factor (LIF) in
the presence of serum (serum ESCs) and in defined “2i” medium
(2i ESCs); the latter condition is thought to promote a more ho-
mogeneous population of naive cells in a “ground” state of pluri-
potency (31). The depletion of feeders from v6.5 cells resulted in a
2- to 3-fold diminution in the overall level of Tet1 transcripts,
associatedwith increased spontaneous differentiation, but the lev-
els of exon 1b consistently exceeded those of exon 1a by 5- to
6-fold (5.5- 0.5-fold) (n 3) and were comparable to the levels
in the feeder-independent ESC lines CJ7 and E14Tg2a grown in
serum (Fig. 1C; see also Fig. S2D in the supplemental material).
Culture in 2i, which sustains cells as undifferentiated rounded
colonies, caused a modest reduction in overall Tet1 expression
levels compared to those in serum ESCs but retained the relative
exon 1b/1a expression ratio of about 5 (4.8 0.7):1 (n 6) (Fig.
1C). The latter finding is in agreement with previous studies de-
scribingmodest or variable differences inTet1 expression between
Sohni et al.
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2i and serum conditions (32–34). Although we cannot formally
rule out that individual cells may selectively activate one TSS over
the other without single-cell analysis, our results suggest that the
two TSSs are more likely to be concurrently active in each cell.
To investigate further whether Tet1 expression changes during
early postimplantation development, we used a recently reported
protocol to differentiate 2i ESCs into epiblast-like cells (EpiLCs)
in 48 h (35). The converted EpiLCs displayed a gene expression
profile similar to that of early, pre-primitive-streak stage postim-
plantation embryos, as previously described (6), representing a
state of primed pluripotency (see Fig. S2E in the supplemental
material). In EpiLCs, the Tet1 transcript profile remained similar
to that in 2i ESCs, although the ratio of exon 1b/1a decreased to
3.3  0.5 (n  4). In contrast, mouse epiblast-derived stem cells
FIG 1 Identification of an ESC-specific TSS in Tet1. (A) Alignment of 5=-RACE clonal products from v6.5 ESCs to Tet1 (mm9) by using the BLAST-like
alignment tool (BLAT) shown in the UCSC genome browser view. The number of clones sequenced is indicated in parentheses (see Fig. S1 in the supplemental
material). An Ensembl transcript is also shown, with exon 1 labeled 1c. The positions of qPCR detection primers are indicated (see Fig. S2A in the supplemental
material). At the bottom, Integrative Genome Viewer (IGV) tracks of ChIP-seq occupancy of the initiating (Pol2_5P) and elongating (Pol2_2P) forms of Pol II
in ESCs (29) are shown. (B to E) Normalized transcript copy numbers detected within the Tet1 5= UTR (exons 1a and 1b) and CDS (exons 12 and 13) in
feeder-cultured v6.5 ESCs and iPSCs (B), in 2i- and serum-cultured v6.5 ESCs in the presence of LIF versus EpiLCs and EpiSCs (C), in mouse embryonic tissues
(D), and in tissues of adultmice (E). The inset in panelD shows the results forMEFs,with an enlarged y axis.Data aremeans SEM from	3 biological replicates.
*, P 0.05.
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(EpiSCs), which were recently shown to resemble the late-gastru-
la-stage epiblast/ectoderm upon in vitro adaptation (36), showed
an altered profile, in which exon 1a transcripts were sustained but
exon 1b transcripts were further diminished to low levels (with a
ratio of exon 1b to 1a transcripts of 0.3 0.1 to 1 n 3) (Fig. 1C).
To correlate these observations with changes in vivo, we exam-
ined native epiblasts of E6.0 to E7.0 early gastrulating mouse em-
bryos and whole embryos at E8.5 to E10.5 postgastrulation stages.
In prestreak stage (E6.0) and early-streak stage (E6.5) mouse epi-
blasts, we observed the expression of exon 1a transcripts at ESC
levels (3.7%  0.3% of Gapdh levels; n  6) and already dimin-
ished levels of exon 1b transcripts (1% of Gapdh levels) (Fig.
1D). The difference between EpiLCs in vitro and E6.0 epiblasts in
vivo suggests that EpiLCsmay correlatemore closely to the E5.0 to
E5.5 epiblasts not examined in this study. Levels of exon 1a and 1b
transcripts declined in mid-streak-stage (E7.0) embryos, becom-
ing more similar to the transcript profile of EpiSCs. By E8.5, exon
1b was no longer detected in whole embryos. TSS at exon 1a sus-
tained low levels of Tet1 expression in E8.5 to E10.5 embryos (0.3
to 1.6% of Gapdh levels) but was further downregulated in pri-
mary cultures of E13.5 mouse embryonic fibroblasts (Fig. 1D). In
the adult mouse, low levels of Tet1 (1% of Gapdh levels) per-
sisted in all tissues examined; of the three 5= transcript variants
examined (exons 1a, 1b, and 1c), only exon 1a was detectable (Fig.
1E). Slightly elevated levels of Tet1 coding transcripts were ob-
served in tissues of the brain (cerebellum, cortex, and hippocam-
pus), as previously described (37, 38), and in the ovaries. Quanti-
tations were similar using primers specific for either exons 4 and 5
or exons 12 and 13 (data not shown). However, in brain tissues
and also in the heart, the exon 1a 5= transcripts consistently did not
account for the higher copy numbers of transcripts detected in the
coding region, suggesting that there are alternative 5= transcripts
not detected by our 5=-RACE and qPCR assays (Fig. 1E). 5= RACE
performed by usingmouse cerebellum cDNA confirmed only one
TSS at exon 1a (data not shown).One possible explanation for this
finding is that transcription initiation occurs in the dispersed
mode over the promoter region upstream of exon 1a. Se-
quences of 5=-RACE clonal products in ESCs that aligned close
to exon 1a (see Fig. S1E in the supplemental material) indeed
suggest TSSs at variant positions within the 200-bp vicinity of
the exon 1a sequence annotated in this study (see Fig. S1F in the
supplemental material), some of which cannot be detected by
our qPCR primers.
Collectively, these results suggest a strong preference for TSS at
exon 1b of Tet1 in the preimplantation ICM and early epiblast,
which rapidly switches to a preference for a TSS at exon 1a in the
postimplantation epiblast. In late-postgastrula-stage embryos and
in the adult soma, only the TSS at exon 1a is weakly active.
Cell state-specific coupling of promoter and enhancer do-
mains in Tet1. To identify cis-regulatory elements in Tet1, we
surveyed its epigenome in mouse ESCs using ChIP-seq data sets
(Fig. 2A; see also Table S2 in the supplemental material). The
combinatorial binding profiles of pluripotency factors, Mediator,
and cohesin units have previously delineated a superenhancer do-
main inTet1, a 15.2-kb region that spans from exon 1c at the distal
end to a conserved noncoding sequence (CNS) upstream of the
CDS (8) (Fig. 2A; see also Fig. S3 in the supplemental material).
ChIP-seq showed strong binding profiles of Oct4 within the CNS,
as previously shown (13), but also severalmore strong peaks in the
distal region between exons 1b and 1c (Fig. 2A).We also examined
specific chromatin signatures of histone H3 lysine 4 trimethyla-
tion (H3K4me3), which marks active promoters, and histone H3
lysine 4 monomethylation (H3K4me1) in combination with the
presence of histone H3 lysine 27 acetylation (H3K27ac) and the
absence of H3K4me3, which frequently marks active enhancers
(39, 40). Consistent with exons 1a and 1b having active TSSs, both
sites were associated with strong and broadH3K4me3marks (Fig.
2A). Signals for H3K4me1 were detected across the entire gene
locus, but the signals for H3K27ac were highly enriched over a
22.9-kb region, which encompasses and extends upstream of
the superenhancer. In ESCs, the gene locus is entirely devoid of
signals for the silencing mark H3K27me3 (data not shown).
Based on these chromatin signatures and binding patterns of
trans-acting factors, we defined two genomic segments as putative
promoter regions: the 5-kb segment A and 6-kb segment B up-
stream of and including exons 1a and 1b, respectively. These seg-
mentswere subcloned as 5=-serially deleted fragments upstreamof
a reporter gene (Fig. 2A). Segment B contains 6 prominent ChIP-
seq peaks that are common binding sites for OSN factors, p300,
andMediator (see Fig. S3 in the supplementalmaterial); therefore,
6 subfragments were tested, which represent truncations to pro-
gressively remove each ChIP-seq peak region (Fig. 2A). The con-
structs were transfected into either mouse v6.5 ESCs or NIH 3T3
cells (a murine fibroblast line, as a nonpluripotent control) for in
vitro reporter assays.
Within genomic region A, all 5 fragments of various lengths
showednopromoter activity in ESCs and lowbasal activity inNIH
3T3 cells (see Fig. S4A in the supplemental material). In contrast,
all fragments within segment B, except for the shortest 0.5-kb
fragment, fragment B1, showed strong promoter activity in ESCs
at least 10-fold (n  4 to 6) above basal levels observed for NIH
3T3 cells, suggesting that the promoter activity within region B is
highly ESC specific (Fig. 2B). The 3.4-kb fragment B4 (base posi-
tions
3242 to168 of TSS at exon 1b) consistently showed the
strongest ESC-specific activity, significantly exceeding the activi-
ties of all other fragments in ESCs. Adjustment of the transfection
ratios of plasmids to account for their different sizes had no ap-
parent effect on their relative activity within the limits of the trans-
fection conditions (see Fig. S4B in the supplemental material). To
determine whether the differences were due to the presence of
enhancer or repressor elements, we tested the individual 1-kb
fragmentsD1 toD4, each compassing anOSNpeak in regionB for
regulatory activity. In reporter constructs driven by either a min-
imal SV40 promoter or the endogenous Tet1 promoter (fragment
B3), all D subfragments caused no effect or only a modest 2- to
3-fold increase in promoter activity (see Fig. S4C and D in the
supplemental material). These experiments showed no evidence
for any strong distal-acting enhancer or repressor constituents
within the D fragments. Alternatively, these regions may function
as cis regulators only in the context of the entire 6-kb promoter.
Thus, we regard the entire 6-kb fragment B6 as a functionally
autonomous full promoter. Fragment B1, with only one OSN
peak region, may constitute a minimal proximal promoter.
We next tested the 1.4-kb fragment E, which compasses the
CNS and anOct-Sox (O/S)motif, for enhancer function (Fig. 2A).
In either orientation, fragment E increased SV40 promoter activ-
ity by 5- to 15-fold (n  5) in ESCs (significantly higher in the
sense [	10-fold] than in the antisense [5- to 10-fold] direction)
and not at all in NIH 3T3 cells, which is indicative of a highly
ESC-specific enhancer (Fig. 2C). We further examined the effect
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FIG 2 Characterization of Tet1 regulatory domains by luciferase assays. (A) Binding profiles of OSN (represented by Oct4 ChIP-seq) (8) and histone H3
modifications (65) over the locus upstream of Tet1 in ESCs. The 5=-UTRs are denoted as gray boxes, and the CDS in exon 2 is denoted as a black box. ChIP-seq
signals are shown as tag densitieswith the y axis floor set to 1. The locus is shown in reverse compared to Fig. 1A. TheCNS (white boxes) is based onmouse-human
conservation and anOct-Sox (O/S)motif, indicated with a vertical line. The superenhancer domain ismarked by a gray line. At the bottom, barsmark fragments
tested, with base positions at the ends denoted with respect to TSS at exon 1a for fragments A and E and with respect to TSS at exon 1b for fragments B and D.
(B to E)Normalized luciferase expression of constructs (shown by figures along the y axes) to test for promoter (B andD) or enhancer (C and E) activities relative
to those of control vectors (set to 1 and shown as dotted lines in panels C and E) in ESCs, NIH 3T3 cells, and EpiLCs. Data are means SEM from	3 biological
replicates. *, P	 0.05.
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of fragment E cloned in the sense direction downstream of endog-
enous Tet1 promoter sequence A or B. Interestingly, fragment E
activated sequence A fragments of various sizes, which all showed
negligible promoter activity by themselves in vitro (see Fig. S4A in
the supplemental material), in ESCs but not in NIH 3T3 cells (Fig.
2D and data not shown). Fragment E enhanced the activity of
fragment B1 by a variable 3.8-  1.4-fold (n  4) but had no
stimulatory effect on the full promoter B6 (Fig. 2D). Thus, frag-
ment E is cis enhancer that regulates Tet1 promoter region A in
ESCs but can be dispensable for promoter region B. To determine
whether fragment E shows similar enhancer activities in EpiLCs,
we performed transfection of the reporter constructs during the
ESC-to-EpiLC transition. Compared to transfection in serum
ESCs passaged in parallel, fragment E remained potent as an en-
hancer in EpiLCs in conjunctionwith either the SV40 promoter or
endogenous Tet1 promoter A (fragment A1) (Fig. 2E). These re-
sults suggest two functionally autonomous domains within the
Tet1 “superenhancer,” each regulating a distinct TSS: (i) the distal
6.2-kb domain B, which appears to be sufficient to activate tran-
scription at exon 1b at a high level, and (ii) the proximal 8.6-kb
domain (spanning A and E), comprising a weak promoter at exon
1a and a proximal intragenic enhancer active in both the naive and
primed pluripotent states.
A pluripotency-independent promoter coupled to an ESC-
specific enhancer in Tet2. By 5= RACE of Tet2, we confirmed a
dominant TSS at exon 1, 56 kb upstream of the annotated CDS,
which aligns with ChIP-seq peaks for Pol2_5P in ESCs (see Fig.
S5A and S5B in the supplemental material). To define the func-
tional promoter region, we examined a 6-kb genomic region up-
stream and inclusive of the 191-bp exon 1 (denoted sequence F)
and subcloned 4 fragments serially truncated from the 5= end (Fig.
3A). All four fragments showed high promoter activity in both
ESCs and NIH 3T3 cells (Fig. 3B). Although the promoter activity
of each fragment was 2- to 4-fold (n 3 to 5) higher in ESCs than
in NIH 3T3 cells, the normalized luciferase activities measured in
NIH 3T3 cells were nonetheless substantial (50-fold above those
of controls without the promoter), suggesting that the promoter
can be functional in either pluripotent or nonpluripotent cells
without additional cis-regulatory elements. The removal of seg-
ment F1 from the 3= ends of fragments F2 and F3 abolished all
promoter activity in ESCs and NIH 3T3 cells (data not shown).
These data suggest that the proximal promoter of Tet2 can be
defined within a narrow locus of 556 bp surrounding the TSS,
consistent with the high density of active H3K4me3 andH3K27ac
ChIP-seq signals in this vicinity and the dearth of these signals
upstream (Fig. 3A).
We previously found an O/S motif within a CNS at base posi-
tion 1788 to 1802 downstream of the Tet2 TSS; this locus
(CNS1) was associated with weak Oct4 binding (13, 25). Two
distal intergenic CNS regions that contain putative O/S motifs, at
kb
140 (CNS2) and kb
200 (CNS3) upstream (see Fig. S6A in
the supplemental material), showed no detectable Oct4 binding
but were subsequently described to be functional enhancers dur-
ing B cell-to-macrophage trans differentiation (41).We tested en-
hancer activity in fragments flanking each O/S motif in the three
CNS regions. None of them showed any enhancer activity (2-
fold increase of SV40 promoter activity; n  3) in ESCs (see Fig.
S6B in the supplemental material). We also examined a longer
2.5-kb intragenic region, fragment G, that overlaps the motif in
CNS1 and the peaks for H3K4me1 and H3K27ac (Fig. 3A). Frag-
ment Gwas also devoid of enhancer activity in ESCs andNIH 3T3
cells (see Fig. S6C in the supplemental material).
To search for other possible ESC-specific Tet2 enhancer ele-
ments, we looked for ChIP-seq peaks elsewhere in the gene. The
superenhancer cluster marked by prominent OSN peaks indeed
lies further downstream in introns 1 and 2 (see Fig. S5C in the
supplemental material). Based on these OSN locations, we exam-
ined 3 regions, regions H, I, and J (Fig. 3A). The 2.8-kb region H
showed strong ESC-specific enhancer activity (	10-fold above
control levels; n 3); in contrast, regions I and J had weak or no
activity (3-fold; n  3 or 4) (Fig. 3C; see also Fig. S6C in the
supplemental material). By splitting region H into two 1.1- to
1.2-kb subfragments, fragments H1 and H2, each corresponding
to an individual OSN peak, we further localized the ESC-specific
enhancer within fragment H1 (Fig. 3C). Similar enhancer activi-
ties (or the lack thereof) were observed for each fragment cloned
in either orientation (see Fig. S6D in the supplemental material).
When cloned downstream of reporter constructs driven by the
already strong promoter fragments F1 and F4, fragment H1
caused a further 3- to 4-fold increase in reporter activities (Fig.
3D). In concert with the loss of Tet2 expression during the ESC-
to-EpiLC transition (see Fig. S2E in the supplemental material),
the enhancer activity of fragment H1 was rapidly downregulated
in EpiLCs compared to the levels in serum ESCs (Fig. 3E). When
enhancer effects on the same mammalian promoter (fragment
A5)were compared,Tet2 enhancerH1was inactivated, in contrast
to the sustained activity of Tet1 enhancer E in EpiLCs (Fig. 3F).
Our results suggest that Tet2 is regulated by a pluripotency state-
independent promoter, but expression can be further increased in
ESCs via a distal intragenic naive-state-specific enhancer.
Contribution of Oct and Sox motifs in Tet1 and Tet2 en-
hancer fragments. To determine whether the O/S motif in Tet1
fragment E (Fig. 4A) binds Oct4 and/or Sox2 in vitro, we per-
formed gel shift assays using a 48-bp DNA probe incubated with
nuclear extracts from mouse ESCs or from HEK293T cells over-
expressing OCT4 and/or SOX2 (Fig. 4B). Two prominent bands
of DNA-protein complexes were generated by ESCs and OCT4-
expressing HEK293T cell extracts. The lower band was lost and
“supershifted” by incubation with an Oct4-specific antibody,
which is indicative of a specific DNA-Oct4 complex (Fig. 4B). The
higher band (Fig. 4B, asterisk), produced by all nuclear extracts,
likely contains the ubiquitously expressed Oct1 (42). Incubation
with nuclear extracts of HEK293T cells overexpressing SOX2
failed to produce any additional band that could be supershifted
by a Sox2 antibody.
We further mutated the Oct4 motif as well as the adjacent 5=
sequence that weakly resembles a Sox2motif [C(A/T)TTGT] (Fig.
4A) (28). In competition binding assays, the formation of com-
plexes between the wild-type (wt)-labeled probe and nuclear ex-
tracts from ESCs and HEK293T cells expressing OCT4 and SOX2
was effectively abolished by cold wt and Sox motif-mutated (Sm)
competitors but not by a cold Oct4motif-mutated (Om) compet-
itor probe (Fig. 4C; see also Fig. S7A in the supplemental mate-
rial). We conclude that Oct4 binds directly to its cognate octamer
element within fragment E, but in vitro Sox2 binding could not be
detected under the conditions of our assay.
To test whether the Oct4 motif is functionally critical for en-
hancer activity, we first divided fragment E into two parts, in
which the Oct4 motif was in the 3= portion. Surprisingly, the 5=
half retained enhancer activity without the Oct4 motif, but the 3=
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half lost all stimulatory effects (Fig. 4D). Mutation of the Oct4
motif within the full fragment E also did not abolish but instead
increased enhancer activity, whereas mutation of the Sox2 motif
had no significant effect (n 5) (Fig. 4E; see also Fig. S7B in the
supplemental material). Thus, both deletion and mutation analy-
ses showed that the Oct4 motif in fragment E, despite binding
Oct4 in vitro, is dispensable for enhancer function.
The lack of enhancer function at the 3= end of fragment E
prompted us to examine the 5= part for other putative elements.
Indeed, we identified a sequence (CCTTTGT) resembling a Sox2
motif (Fig. 4F). Using extracts from ESCs and HEK293T cells
overexpressing SOX2, we observed complexes binding to a DNA
probe containing the putative motif (labeled 5= Sox to distinguish
from the 3= Sox-Oct motif shown in Fig. 4A). The Sox2 antibody
FIG 3 Characterization of Tet2 regulatory domains by luciferase assays. (A) Same as the legend to Fig. 2A with respect to Tet2. (B to F) Normalized luciferase
expression of constructs in ESCs, NIH 3T3 cells, and EpiLCs. *, P 0.05.
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caused a variable blockage of complex formation but did not cause
any detectable supershift (Fig. 4G; see also Fig. S7C in the supple-
mentalmaterial). Both coldwt and Soxmotifmutant probes com-
peted with the labeled probe, although the mutant probe was less
effective than the wt, suggesting that Sox2 likely binds in vitro to
sites other than its putative motif within the probe. Nonetheless,
mutation and deletion of the 5= Sox motif significantly reduced
the enhancer activity of fragment E on either the SV40 promoter
or the endogenousTet1 promoter A (fragment A5) by50% (Fig.
4H; see also Fig. S7B in the supplemental material). Together, our
results support that Sox2 binds at a different site (5=) from the
Oct4 site (3=) within fragment E; however, binding is not fully
specific to the Sox motif, consistent with a partial contribution of
the motif to enhancer function. In addition to the Sox2 motif, a
putative Nanog motif (GNNCATTNNC) (8) was found at the 5=
end of fragment E (see Fig. S7D in the supplemental material).
Despite possible Nanog binding to a probe sequence containing
the motif, mutation or deletion of the motif had no effect on
fragment E enhancer activity (see Fig. S7B, E, and F in the supple-
mental material).
Tet2 enhancer fragment H1 harbors a putative Oct-Sox motif
(Fig. 4I). A probe containing this motif indeed formed complexes
with ESC extracts in gel shift assays (Fig. 4J). Incubation with an
Oct4 antibody but not a Sox2 antibody produced a supershift.
However, both coldOmand Smprobes competedwith the labeled
probe for binding, although competition by the Om probe ap-
peared to be partial, suggesting thatOct4 binding can also bemotif
independent. Neithermutation nor deletion of the entire Oct-Sox
motif affected fragment H1 enhancer activity in vitro (Fig. 4K),
suggesting that Oct4 may regulate the Tet2 enhancer in an motif-
independent manner.
Cell type-dependent regulationofTet1byDNAmethylation.
Murine Tet1 exon 1a overlaps a CpG island typical of manymam-
malian promoters and thus is expected to contain the canonical
TSS. A previously reported Tet1 ChIP-seq data set also demon-
strated Tet1 binding at exon 1a (see Fig. S3 in the supplemental
material), suggesting that Tet1 regulates its own promoter (43). In
contrast, exon 1b is associated with a distal CpG-poor region with
low-level conservation (50%)with the human genome. In lucif-
erase assays, we noted that B fragments had low but detectable
basal activity in NIH 3T3 cells (10% of ESC levels), which may
be attributed to a core promoter activity (Fig. 2B). However, Tet1
transcripts of exon 1b were not detected in mouse embryonic
fibroblasts (MEFs) (Fig. 1D). DNase I hypersensitivity site (DHS)
profiles (44) revealed that chromatin accessibility in segment B is
very high in ESCs, with individual DHS peaks corresponding to
the OSN peaks, but is lost in NIH 3T3 cells (Fig. 5A). Base-reso-
lution whole-genome bisulfite sequencing (WGBS) maps (45)
also revealed differential methylation between ESCs and neuronal
progenitor (NP) cells within this region, which is indicative of
promoter silencing during differentiation (Fig. 5A). We therefore
investigated whether there is epigenetic regulation at the pro-
moter regions of Tet1 by DNA methylation.
We examined the methylation status at CpG sites within or
flanking four of the DHS/OSN peaks (D1- to D4-bis denoting loci
analyzed) by bisulfite sequencing. All four sites were unmethy-
lated or methylated at low levels (20%) in ESCs and completely
unmethylated in 2i cultures (Fig. 5B and data not shown). Meth-
ylation increased marginally in EpiLCs but reached high levels
(	70%) in EpiSCs, MEFs, and adult tissues (Fig. 5B; see also Fig.
S8A in the supplementalmaterial). In native E6.0 to E7.0 epiblasts,
the D1-bis site was already highly methylated, consistent with the
diminished levels of exon 1b transcripts compared to those in
ESCs and EpiLCs. Traditional bisulfite sequencing cannot dis-
criminate between 5mC and 5hmC among “methylated” cyto-
sines (46). However, global 5hmC levels are very low relative to
those of 5mC in murine fibroblasts (13, 38). Moreover, Tet-as-
sisted bisulfite sequencing (47) of selectedmethylated loci showed
hardly any 5hmC (see Fig. S8B in the supplemental material). To
confirm that methylation (and not hydroxymethylation) causes
silencing of the promoter region B, we performed in vitro meth-
ylation of fragments B1 to B3, including an additional fragment
containing the D1-bis site (fragment B2D1-bis), in the reporter
plasmids by using CpG methyltransferase. Transfection of the
methylated plasmids containing all promoter B fragments re-
sulted inmarkedly reduced levels of reporter activity compared to
that in unmethylated plasmids, down to the basal levels driven by
the minimal SV40 promoter, which was unaffected by methyl-
ation (Fig. 5D). In fact, methylation of only 4 CpG sites in frag-
ments B1 and B2, which are within anOSNChIP-seq peak and the
DHSmost proximal to exon 1b (Fig. 2A and 5A), was sufficient to
reduce reporter activity by 90%. Together, these results are reflec-
tive of a differentially methylated regulatory (DMR) domain
within Tet1 promoter region B that regulates transcription from
exon 1b. Consistent with dynamic developmental-stage-specific
changes in DNA methylation confined mostly to CpG-poor reg-
ulatory regions (48), these results emphasize the need for base
resolution and a CpG density-unbiased approach to unravel new
critical DMR domains at specific gene loci.
We also examined a region flanking the CpG island at exon 1a
FIG 4 Contribution ofOct-Soxmotifs toTet1 andTet2 enhancer function. (A) TheO/Smotif inTet1 fragment Ewithmutationswithin theOct4 (Om) and Sox2
(Sm) motifs. (B) Electrophoretic mobility shift assay (EMSA) of a Tet1 probe incubated with nuclear extracts (NE). Lanes: 1 and 10, free probe only; 2,
mock-transfected HEK293T cells (M); 3 to 9, HEK293T cells overexpressing either OCT4, SOX2, or OCT4 and SOX2; 11 to 13, v6.5 ESCs. Supershifts were
performed by adding Oct4 (lanes 4, 8, and 12)- or Sox2 (lanes 6, 9, and 13)-specific antibodies. The supershifted Oct4-DNA complex is marked with an
arrowhead. The topmost band (asterisk) indicates the shift by Oct1. At the bottom, the 48-bp probe sequence is shown with the Oct4 motif in boldface type and
the Sox2 motif is underlined. (C) Competition EMSA of the labeled Tet1 probe (as shown in panel B) incubated with NEs from ESCs (lanes 2 to 5) with the
indicated cold competitor oligonucleotides. (D and E) Enhancer activity of Tet1 fragment E upon truncations (D) or mutations (E) of the O/S motif in ESCs. *,
P 0.05 by matched Dunnett’s test; n.s., not significant. (F) Sox2motif at the 5= end of fragment E and the mutated sequence Sm. (G) EMSA of the labeled Tet1
5=-Sox probe (sequence at the bottom with the motif underlined) incubated with NEs from mock-transfected HEK293T cells (lane 2), HEK293T cells overex-
pressing SOX2 (lane 3), or mouse ESCs (lanes 5 to 8) with the addition of Sox2 antibody or competitor probes, as indicated. (H) Enhancer activity of Tet1
fragment E uponmutation or deletion () of the 5=-Sox2 motif in ESCs. *, P 0.05 by matched Dunnett’s test. (I) Putative O/S motif in Tet2 fragment H1 with
mutations within the Oct4 (Om) and Sox2 (Sm)motifs. (J) EMSA of the labeledTet2 probe (sequence at the bottomwith the Oct4motif in boldface type and the
Sox2 motif underlined) incubated with NEs from mouse ESCs with the addition of antibodies or competitor probes, as indicated. In lanes 6 to 11, NEs were
loaded in two amounts (2 or 4l), as indicated by the rising bars. The supershifted Oct4-DNA complex is marked with an arrowhead. The arrows (lane 4) mark
the bands partially competed by the cold Om probe. (K) Enhancer activity of Tet2 fragment H1 upon mutation or deletion () of the O/S motif in ESCs.
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of Tet1 (CGI-bis). Clonal bisulfite analysis of 25 of the 46 CpG
sites within the CpG island revealed a similar low-methylation
state (15%) in all embryonically derived and somatic cells, in-
cluding adult liver and brain tissues (Fig. 5B and C; see also Fig.
S8A in the supplemental material). In NIH 3T3 cells, the levels of
methylationwere higher in regionA (28.9%) but lower in regionB
(represented by D1- to D4-bis) than those detected in MEFs,
which is suggestive of aberrant de novo methylation at the CpG
FIG 5 Analysis of DNAmethylation atTet1 sites by bisulfite sequencing. (A) The 5= genomic region ofTet1 (Fig. 2A) showing domains of interest. The white box
indicates the position of a CpG island containing 46 CpG sites. Below the scheme are ENCODE tracks for DHSs (44) andWGBSmethylomemaps (45) of mouse
ESCs versusNIH 3T3 cells or neural progenitors (NP). At the bottom, loci for bisulfite analysis are indicated by horizontal lines. (B andC)Methylation of specific
Tet1 loci (size shown in base pairs in parentheses and with relative positions of CpGsmarked by vertical lines) in v6.5 ESCs, EpiLCs, EpiSCs,MEFs, andNIH 3T3
cells (B) and in E6.0 to E7.0 epiblasts (C). Closed circles denote 5mC (or 5hmC); open circles indicate unmethylated C;  indicates a missing sequence or
mismatch. Results are representative of 2 or 3 independent experiments. Where there are7 clonal sequences from each conversion, sequences from additional
experiments (separated by a space) are added. Values at the top indicate overall methylation levels (percent) of the sequences shown. ND, not determined. (D)
Effect of DNA methylation on normalized luciferase activities of reporter plasmids.
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island and hypomethylation at CpG-poor sites unique to tumor
transformation. DHS profiles also showed that this is one of few
regions at the Tet1 locus, including one site 6 kb downstream
with a differential CCCTC binding factor (CTCF) binding pat-
tern, that retains an open chromatin in both ESCs and NIH 3T3
cells (Fig. 5A). An adjacent locus 5= of the CpG-poor enhancer E
wasmethylated at low levels (20%) in ESCs, EpiLCs, and E6.0 to
E6.5 epiblasts; it gained intermediate methylation states (20 to
40%) in EpiSCs and E7.0 epiblasts and became highly methylated
in MEFs (75.3%) and other somatic tissues (liver [94.4%] and
brain [87.7%]) analyzed (Fig. 5B and C; see Fig. S8A in the sup-
plemental material). Similarly, the CTCF binding site further
downstream was methylated at low levels (20%) in ESCs,
EpiLCs, and EpiSCs but at high levels in MEFs (59.4%) and NIH
3T3 cells (63.6%), in an inverse relation to CTCF binding (Fig. 5B
anddata not shown). Thus, the entire gene locus upstreamofTet1,
except for the CpG island region, eventually gained methylation
associated with the silencing of promoter region B early and en-
hancer region E later during differentiation.
The active TSS of Tet2 is flanked by a high-density CpG island.
Both DHS and WGBS profiles for this genomic region suggest an
open chromatin with low-level methylation in both pluripotent
and differentiated cells (see Fig. S8C in the supplemental mate-
rial). Clonal bisulfite sequencing analysis of 33 of 115 CpG sites
within the CpG island indeed revealed that this locus was com-
pletely unmethylated in ESCs, EpiLCs, EpiSCs, and MEFs, al-
though there was a notable increase in methylation (to 37.9%) in
NIH 3T3 cells (see Fig. S8D in the supplemental material). The
intragenic enhancer region H1 was methylated at low levels in
ESCs, EpiLCs, and E6.0 to E7.0 epiblasts (15%) but was meth-
ylated at intermediate levels (30 to 50%) in EpiSCs andMEFs (see
Fig. S8D and S8E in the supplemental material), suggesting that
this enhancer may not be regulated by DNA methylation during
exit from pluripotency.
We further investigated the dynamics of transcriptional and
methylation changes at Tet1 during differentiation using an in
vitro assay of LIF and feeder withdrawal and supplementation
with all-trans retinoic acid (RA). As previously reported, Tet1 and
Tet2 transcripts were rapidly downregulated concomitantly with
Oct4 within 2 days of LIF withdrawal and RA induction (13). We
measured Tet1 transcript levels from exons 1a and 1b and coding
regions during this time course by qPCR. Exogenous LIF sus-
tained Tet1 expression for at least 3 to 4 days, although total tran-
script levels progressively decreased to 2 to 4% of Gapdh levels
upon feeder-free adaptation (Fig. 6A). Upon RA-induced differ-
entiation, the expression of exon 1b rapidly diminished within 24
h and was undetectable by 2 days. In contrast, the expression of
exon 1a persisted at lower levels in both LIF-cultured and differ-
entiating cells (Fig. 6A). Thus, the decline of total Tet1 levels dur-
ing RA-induced differentiation is reflected by changes in exon 1b
and not exon 1a transcripts.
Consistentwith sustainable exon 1a expression, theCpG island
region proximal to exon 1a stayed unmethylated during the entire
differentiation time course (see Fig. S9A in the supplemental ma-
terial). The downstream CTCF site also stayed methylated at sim-
ilarly low levels (40%) in both the LIF-sustained andRA-treated
(in the absence of LIF) groups (see Fig. S9B in the supplemental
material). Although the CTCF site stayed unmethylated during
this early differentiation time course, it wasmethylated later in the
somatic lineage (Fig. 5B).
To track the methylation changes in genomic region B of Tet1,
we focused on the two DMR sites D1- and D4-bis. In the presence
of exogenous LIF, methylation levels at site D1 stayed low
(30%), at a level typical of feeder-free adapted ESCs grown in
serum, and increased only marginally to 34.8% at day 3, along
with increased spontaneous differentiation. Upon RA-induced
differentiation, methylation exceeded 50% by 48 h and reached a
high level of 70% by day 3 (Fig. 6B). Overall, the kinetics of meth-
ylation gain at site D1-bis appeared to be tightly associated with
the loss of exon 1b expression and further supports DNAmethyl-
ation at this locus as a transcriptional silencing mark. In contrast,
methylation of the D4 locus showed fewer differential changes
during differentiation (Fig. 6C). Under both LIF-supplemented
and RA-induced differentiating conditions, site D4-bis progres-
sively increased methylation to 50 to 60% during the first 2 days
and displayed differential methylation only at day 3 (48.0% versus
80.0%). Thus, themethylation changes at site D4 did not correlate
with transcript levels of exon 1b but may prime the region for
silencing by differentiation cues. From these kinetics analyses of
methylation changes at selected loci inTet1, we infer that awave of
chromatin compaction progresses from the distal border toward
the gene body during cellular differentiation but preserving a con-
stitutive open region in the CpG island at exon 1a.
Sufficiency ofTet1 promoter domainB.To determine whether
the 6-kb genomic segment B of Tet1 can function autonomously
to mimic physiological patterns of gene expression, we placed
fragment B6 upstream of the mCherry fluorescence reporter and
stably introduced the construct into ESCs (Fig. 7A). Two puromy-
cin-resistant clones with bright fluorescence were selected for fur-
ther analysis. Flow cytometry showed that 	80% of cells from
feeder cultures expressed the reporter, although all of them ex-
pressed high levels of the naive surface marker CD31 (Fig. 7B and
data not shown; see also Fig. S10 in the supplemental material).
We speculate that 20% of the cells from each clone may have
undergone epigenetic silencing at the transgene during culture,
even in the absence of spontaneous differentiation. When these
clones were feeder depleted and induced to differentiate by using
the same RA treatment as the one described above, fluorescence
diminished in 2 days, similar to the kinetics of downregulation of
the endogenous exon 1b transcripts (Fig. 7C and D; see also Fig.
S10 in the supplemental material). Thus, our Tet1 fragment B6
transgenic reporter system faithfully mimics endogenous pro-
moter activity, at least in vitro, and shows that the 6.2-kb promoter
fragment B is sufficient to regulate transcription from exon 1b.
DISCUSSION
In this study, we defined two distinct TSSs in Tet1 and additional
cis-regulatory elements in both Tet1 and Tet2 that account for
their tissue- and development-stage expression patterns. The dy-
namic coupling of active promoter and enhancer domains in Tet1
causes a switch in dominant TSS usage during the transition from
naive to primed pluripotent states, when expression from the
gene-proximal TSS is sustained by a neighboring enhancer, and a
further loss of expression in differentiated cells when both distal
promoter andproximal enhancer regions are silenced. In contrast,
Tet2 transcription is driven by a non-ESC-specific promoter, but
high levels are sustained in naive ESCs by a distal intragenic en-
hancer that is rapidly inactivated in primed epiblast-like cells.
Our results account for the different tissue-specific expression
patterns ofTet1 andTet2previously reported in themouse (37, 38,
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49). Unlike in the mouse, TET1 levels remained stable during
differentiation of human ESCs (14). Our study resolves this dis-
crepancy by demonstrating that postimplantation mouse epiblast
and epiblast-derived stem cells, which share characteristics more
similar to those of human ESCs (50), already lost the bulk of Tet1
expression via exon 1b and sustained Tet1 expression predomi-
nantly by using TSSs at exon 1a. Indeed, 5= RACE analysis of the
H9 human ESC line confirmed that TET1 transcription starts
from the annotated exon 1 homologous to exon 1a in the mouse
(data not shown). Thus, the high Tet1 expression levels observed
for mouse ESCs and iPSCs arise from the activation of a second
promoter in the naive pluripotent state. Although not tested, we
predict that high expression levels ofTet1 in primordial germ cells
(15) are induced via strong transcription initiation from exon 1b.
A recent study defined conditions to “reset” human ESCs to
ground-state pluripotency, in which elevated TET1 expression
was observed (51). Whether an analogous alternative TSS and
promoter region can be activated in naive-state human ESCs re-
mains to be confirmed, but if indeed proven so, they will be valu-
able tools to discern truly naive-state human cells derived under
alternative culture conditions.
Recent methylome analyses revealed that mouse 2i ESCs de-
velop a global hypomethylated state, associated with the suppres-
sion ofDnmt3a/Dnmt3b/Dnmt3L, whichmimics the early ICM; in
comparison, serum-cultured ESCs acquire de novo methylation
and increased expression ofDnmt3bmore typical of the epiblast in
late blastocysts (32, 33). Those studies analyzed feeder-free ESCs,
and it is unclear how feeder-cultured ESCs correlatewith the ICM.
We consistently observed higher levels of Tet1 expression from
both TSSs in feeder-cultured than in feeder-free ESCs. A previ-
FIG 6 Time course of DNAmethylation changes at Tet1 sites during in vitro differentiation. (A) Normalized copy numbers of Tet1 transcripts in ESCs upon LIF
withdrawal and the addition of 1M retinoic acid (RA). Expression values are means SEM (n 3). (B and C)Methylation of two sites (sites D1- and D4-bis)
during the time course. Data are representative of 2 independent experiments. Where there are9 clones, sequences from the second experiment are added.
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ously reported single-cell RNA sequencing analysis showed that
ESCs (feeder cultured) aremolecularly distinct from the E3.5 ICM
and E4.5 epiblasts (52) and, by extrapolation, may also be distinct
from feeder-depleted ESCs. Nonetheless, our results suggest that
preimplantation development in the mouse involves higher Tet1
transcription levels, which are suppressed by the postimplantation
stage. The transition from the preimplantation ICM (E3.5) to
postimplantation epiblasts (E6.5) is associated with a global gain
of DNA methylation (53). The physiological function of Tet1 has
been proposed to be that of a “maintenance”DNAdemethylase to
maintain the fidelity of DNA methylation patterns (54, 55). Col-
lectively, our results are consistent with a developmental model in
which a burst of Tet1 transcription accompanies the upregulation
ofDnmt3a/Dnmt3b in the transition from the early to late ICM to
regulate de novo DNA methylation.
An epigenome comparison of naive ESCs and primed EpiSCs
revealed the presence of “seed” enhancers, which are dormant in
ESCs but activated in EpiSCs to take over primary transcriptional
control of genes that are similarly expressed in either cell state (7).
By this definition, the proximal enhancer E ofTet1 is neither a seed
nor a “poised” enhancer because total Tet1RNA levels weremuch
higher in ESCs than in EpiSCs; moreover, enhancer E demon-
strated in vitro activity in both cell states (Fig. 2E). Nonetheless, a
striking analogy to the master pluripotency gene Oct4 can be
drawn. The distal enhancer ofOct4, also the densest binding locus
for key pluripotency transcription factors in ESCs (56), drives
Oct4 expression in preimplantation embryos, primordial germ
cells, and ESCs but not in postimplantation epiblasts, whereas the
proximal enhancer directs postimplantation epiblast-specific ex-
pression (57).
Enhancers are classically described as position and orientation
independent. Tet1 fragment E is unique in showing significantly
higher enhancer activity when cloned in the sense than in the
antisense direction in vitro. This is inconsistent with the model of
transcription factor binding and activation in which recognition
of cognatemotifs can occur in either orientation (3).We speculate
that there is an involvement of enhancer-associated noncoding
RNA (ncRNA or eRNA), which is detectable by genomic run-on
sequencing (GRO-seq) over theTet1 superenhancer (see Fig. S3 in
the supplemental material). The precise biological functions of
these enhancer-like RNAs, which are transcribed bidirectionally,
are only beginning to be understood, including a role in facilitat-
ing chromatin looping and transcription via an interaction with
Mediator (58). The presence of an SV40 late poly(A) signal in our
luciferase construct in proximity to the enhancer cloning site may
have interfered with ncRNA production in one direction.
FIG 7 Characterization of aTet1 fragment B6 transgene reporter ESC line. (A) Plasmid construct of a 6-kb exon 1b-associated promoter fragment (fragment B6)
subcloned to drive expression of mCherry and a drug-selectable marker. (B, left) Fluorescence image (shown next to the bright-field image) of a selected clone
grown on feeders. (Right) Flow cytometry. (C andD) Fluorescence images (C) and flow cytometry (D) of cells harvested daily during in vitro differentiation.Data
are representative of 3 independent experiments.
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A previous study reported that Tet2 is regulated by Oct4 (25).
The authors of that study cloned a 2.4-kb genomic fragment, from
base position 
420 upstream of the TSS to base position 1980
downstream in the intronic region encompassing the conserved
O/S element in CNS1 (Tet2L) upstream of a reporter. By cotrans-
fecting the reporter plasmid into NIH 3T3 cells with expression
plasmids, those authors demonstrated that Oct4, but not Sox2, is
necessary for Tet2 transcription (25). In contrast, we showed that
the minimal promoter region of Tet2 placed immediately up-
stream of the reporter gene is active in both pluripotent and non-
pluripotent cells, even without the octamer element. Our results
are consistent with the broad expression ofTet2 across tissue types
in the soma by virtue of its pluripotency-independent promoter.
A previous analysis of ChIP-seq data from mouse ESCs (56)
showed the binding of multiple pluripotency-associated tran-
scription factors to a single cluster 12.5 to 22.3 kb upstream of the
Tet1 gene, corresponding to genomic region B defined in this
study (59). However, an Oct4 site was lacking in this cluster. Here
we used a more recent ChIP-seq data set (8), which revealed sim-
ilar binding sites within region B formany of these factors, includ-
ing Oct4. Sequence analysis of the superenhancer region revealed
only one O/S composite element in Tet1 region E. Here we vali-
dated that the composite motif indeed binds Oct4 (but not Sox2)
directly in gel shift assays, consistent with the 100% match with
the Oct4 consensus motif but a much weaker match for Sox2.
Surprisingly, both composite Oct4-Sox2motifs in Tet1 (fragment
E) and Tet2 (fragment H1) enhancer fragments are not necessary
for enhancer function. The lack of contribution by amotif in an in
vitro luciferase reporter assay does not preclude a function in vivo
in the native chromatin context. Nonetheless, our results support
motif (sequence)-independent binding of transcription factors at
high-occupancy target (HOT) regions (60, 61).
By switching in vitro culture conditions of ESCs to mimic dif-
ferent states of embryonic development, together with analyses of
early-postimplantation-stage epiblasts, we propose that the tran-
sition from pre- to postimplantation development involves a dra-
matic change in the transcriptional landscape at both theTet1 and
Tet2 gene loci so as to sustain Tet1 expression via TSSs at exon 1a
but rapidly downregulate Tet2 in the postimplantation, prestreak
epiblast. In view of the very low levels of Tet2 and Tet3 expression
in the pre- and early-streak mouse epiblasts, Tet1 appears to be
the predominant 5-methylcytosine oxygenase expressed at these
stages (R. Khoueiry and K. P. Koh, unpublished data). In contrast
to the pluripotency genesOct4 andNanog, Tet1 levels may decline
rapidly during differentiation but are not completely silenced. The
presence of a non-cell type-selective, albeit weak, promoter at
exon 1a would contribute to low-level Oct4-independent expres-
sion of Tet1 in the postgastrulation embryo and adult soma, par-
ticularly in the brain (62, 63). Full functional validation of the
cis-regulatory elements described in this study will require further
studies to remove specific sequences in cells and in transgenic
mice. The precise physiological relevance ofTet1 expression in the
early embryo also warrants further investigation by using strate-
gies to abolish gene expression completely in the mouse.
Recent studies support a role of Tet1 and Tet2 in epigenetic
reprogramming by facilitating DNA demethylation of Oct4 and
other genes; Tet1 can even replace Oct4 in the classical 4-factor
cocktail (64). Many studies have relied on Oct4-green fluorescent
protein (GFP) and Nanog-GFP reporters to select iPSCs. New
transgenic reporters based on Tet1 and Tet2 will be valuable tools
to unravel the mechanisms of their gene activation during repro-
gramming and ultimately provide insights into the acquisition of
different induced pluripotent states and epigenetic memory.
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